Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. [electronic resource]
- PLoS genetics Mar 2013
- e1003394 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1553-7404
10.1371/journal.pgen.1003394 doi
Adult Aged Alleles Antigens, CD--genetics Antirheumatic Agents--administration & dosage Arthritis, Rheumatoid--drug therapy Asian People--genetics Biomarkers, Pharmacological--metabolism Etanercept Female Gene Expression Regulation Genome-Wide Association Study Humans Immunoglobulin G--administration & dosage Male Middle Aged Polymorphism, Single Nucleotide Receptors, Tumor Necrosis Factor--administration & dosage Signaling Lymphocytic Activation Molecule Family Tumor Necrosis Factor-alpha White People--genetics